Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells

Class:IdLiteratureReference:2008185
_displayNameGlycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells
_timestamp2011-11-21 23:55:24
author[Person:2008183] Fernandes, H
[Person:2008181] Cohen, S
[Person:2008184] Bishayee, S
created[InstanceEdit:2008182] Orlic-Milacic, Marija, 2011-11-21
journalJ Biol Chem
modified[InstanceEdit:2008186] Orlic-Milacic, Marija, 2011-11-21
pages5375-83
pubMedIdentifier11087732
titleGlycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells
volume276
year2001
(literatureReference)[Reaction:1248002] Ligand-independent dimerization of EGFRvIII mutant [Homo sapiens]
[Pathway:5637812] Signaling by EGFRvIII in Cancer [Homo sapiens]
[FailedReaction:5638137] EGFRvIII cancer variant does not bind EGF ligand [Homo sapiens]
[Summation:1181246] Signaling by EGFR is frequently activated in cancer through ...
[Change default viewing format]
No pathways have been reviewed or authored by Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells (2008185)